VmatchNL - a user-friendly graphical interface for large-scale genome analysis
VmatchNL - a user-friendly graphical interface for large-scale genome analysis
批准号:
7109734
负责人:
CHARLES J. LINK
金额:
$9.97万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-09-01 至 2007-02-28
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The availability of a reference human genome sequence provides the foundation for studying the genetic and molecular basis of human health and disease. Using a variety of modern technologies to study differential gene expression, large numbers of researchers in both academic and industrial settings look for causative effects of activation or repression of particular genes and gene products with respect to the onset and progression of disease. Bioinformatic and computational approaches play a critical role in such studies. NewLink Genetics Corporation is a biopharmaceutical company developing novel drugs and functional genomics solutions with a primary focus on cancer. The company has its own proprietary technology for target gene discovery. To facilitate its in-house bioinformatic analysis, NewLink has licensed software for gene structure prediction from Iowa State University and software for genome-scale sequence matching ("Vmatch") from Prof. Stefan Kurtz, University of Hamburg, Germany. These programs are key components of NewLink's internal target-discovery bioinformatics pipeline. Vmatch is a versatile string matching application based on enhanced suffix arrays. Recognizing that there are hundreds of other companies with similar bioinformatics needs, NewLink acquired the exclusive distribution and development rights to Vmatch and is now licensing this program to for-profit customers (an academic version of the programs remains freely available to non-profit researchers). This SBIR proposal seeks funds to develop VmatchNL, a GUI driven application of the Vmatch software. The overall goals of our business are to integrate all software into a GUI-driven, industry-quality, comprehensive platform for target gene discovery ("TargetSeqerNL"). The market for these products includes other small companies that do not have the resources to develop similar capabilities in-house, big companies that look for the superior performance of GeneSeqer and Vmatch relative to other programs, and also to academic researchers with similar needs to organize and analyze their gene expression data.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Improved influenza A virus vaccines using alpha-Gal epitope modification
-
批准号:7538785
-
项目类别:
-
资助金额:$28.76万
-
财政年份:2008
-
负责人:CHARLES J. LINK
-
依托单位:
Improved influenza A virus vaccines using alpha-Gal epitope modification
-
批准号:7688152
-
项目类别:
-
资助金额:$29.12万
-
财政年份:2008
-
负责人:CHARLES J. LINK
-
依托单位:
海外基金